2015 Archived Content

March 31 - April 1, 2015


Building on its inaugural success and back with new and expanded tracks, CHI’s 2nd Annual PEGS China selects and presents key trends, latest case studies and leading players in the worldwide biopharmaceutical industry who are pushing the envelope in protein and antibody engineering. The Summit will provide you with the scientific knowledge and technical know-how that will help advance your biologics to the next phase of development, be they ADCs, bispecifics, novel proteins, antibody constructs or biosimilars.

This 3-day event is THE meeting place for international and China scientists to come face-to-face and share case studies and project updates, explore new techniques, hear innovative ideas, and form new collaborations or solidify existing partnerships.

Meet and hear from our distinguished international Speaker Faculty including these Keynotes & Featured Speakers:  

Chengbin WuAntibody Development Strategies in Today’s China

Chengbin Wu, Ph.D., President, Research & Development and CSO, Shanghai C P Guojian Pharmaceutical Co. Ltd., PR China


Shu-Hui LiuADCs: Is It Time to Rethink Some Preconceptions?

Shu-Hui Liu, Ph.D., Assoc Research Fellow, Department of Biology, Rinat-Pfizer


Zhenping ZhuDesigning and Engineering Novel Bispecific/ Bifunctional Antibodies and Fusion Proteins for Enhanced Antitumor Activity

Zhenping Zhu, Ph.D., Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation


Chandrashekar GanesaWhose Problem Is Post-Translational Modifications? Discovery, Cell Culture, Chromatography or Formulation?

Chandrashekar Ganesa, Ph.D., Senior Director, Analytical Development, Global Biotherapeutics, Sanofi


Robb KahnCurrent Clinical Experience with Antibody-Drug Conjugates: A View through the Therapeutic Window

Robb Kahn, M.D., Senior Safety Science Leader, Global Pediatric Oncology Drug Development, Genentech, a member of the Roche Group


Bilikallahalli MuralidharaKinetic and Thermodynamic Landscape of Protein Aggregation

Bilikallahalli Muralidhara, Ph.D., Associate Director, Vaccines & Biologics, Biopharmaceutical Development, MedImmune, Inc.


2015 Conference Programs Include:  

Protein & Antibody Engineering
Explore techniques to enhance antibody binding and specificity, and delve into strategies for design and development of novel scaffolds and next generation bispecific antibodies. More>>>  

Antibody-Drug Conjugates Examine novel payloads, linker technologies and conjugation chemistries, while developing strategies for homogeneity engineering and biophysical characterization of ADCs. More>>>  

Phage & Yeast Display Learn novel discovery and screening strategies to generate antibodies against challenging targets and discover antibodies with optimized efficacy and improved properties. More>>>  

Characterization of Biotherapeutics Appraise different technologies and methods for characterizing novel formats and improving the stability and solubility of biologics and biosimilars. More>>>

Attendees can choose to attend 1 or all 4 of the conferences and benefit from the expansive coverage that only this event offers!

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Register Today!


Download 2017 Brochure
Download 2017 Brochure


Premier Sponsors


Bioinformatics Soultions Inc


Unchained Labs 


Corporate Sponsors




Cold Spring Biotech Corp

GenScript CRO Logo




MaxCyte no tagline


Nanotemper Technologies  




View All Sponsors

View All Media Partners

Promote your company’s latest technology and/or solution at PEGS CHINA. A limited number of agenda presentations (as part of a sponsorship package), exhibit space, branding, and promotional opportunities are available.

Celebrating 25 Years

Track 1

Protein & Antibody Engineering

Track 2

Protein Aggregation & Stability

Track 3


Track 4

Analytical Characterization of Biotherapeutics